Usama, Julpa A.
HRN: 03-59-93 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/07/2026
04/13/2026
IV
300 MG
Q8
CELLULITIS
Checking Initial Appropriateness
04/07/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/07/2026
04/14/2026
IV
4.5g
Q8h
Celluitis Left Foot
Checking Initial Appropriateness